Los Angeles Convention Center
Los Angeles, CA
May 16-20, 2023


Waltham,  MA 
United States

Technology-ready Solutions for Gene Therapy

Repligen is ready to partner with gene therapy developers and Gene Therapy CDMOs, providing technology breakthroughs and high impact solutions for vector and viral vector manuacturing. 

Gene Therapy has immense potential to transform the lives of patients with genetic diseases. As demand for plasmids and viral vectors outpace capacity, a greater than 10-fold and potentially close to 100-fold increase in manufacturing efficiency for the gene therapy reagents is likely required to meet a demand curve that is increasing exponentially.  Repligen integrated solutions aim to meet the needs for intensified processes, higher yields, and improved process quality - setting new standards for modern scalable processes from gene to therapy.

Inspiring advances in bioprocessing, Repligen is a technology leader in filtration, chromatography stystems, process analytics and Protein A ligand development for bioprocessing and gene therapy. Propelled by a culture of innovation and collaboration, and with a focus on cost and process efficiencies, our people and our technologies help address critical steps in the production of therapeutics, vaccines and diagnostics worldwide. Named one of the fastest growing biotech companies in the USA, Repligen is headquartered in Boston, MA.

Brands: OPUS® XCell ATF® Spectrum® Hollow Fiber Filters TangenX® Flat Sheet Cassettes ProConnex® Flow Paths KrosFlo® Systems ARTeSYN® Systems CTech™ AVIPure® Affinity Resins